{
    "Question": "Biot Korea Inc. CES 2024 product highlight and specification",
    "Summary": "Biot Korea Inc.\n\nProduct: Stem Cell Navigator and RAPIDS Platform\n\n- The Stem Cell Navigator is an innovative medical robot platform designed to precisely deliver medicines to painful areas without major invasion, maximizing treatment efficacy by targeting micro-sized scaffold conjugated with therapeutic material through electromagnetic actuation.\n- The micro-sized scaffold encapsulates stem cells, biologics, and conventional drugs, enabling minimally invasive surgery.\n- RAPIDS is a state-of-the-art One-Stop system that minimizes cross-infection between medical staff and patients, allowing non-face-to-face sampling and molecular diagnosis in the pandemic era.\n- It is the world's first medical robotic system that can be remotely controlled to collect specimens, enabling non-contact and remote-controlled nasopharyngeal and oral specimen collection without risking health workers' exposure to pandemic diseases.",
    "Summary_cn": "Biot Korea Inc.\n\n产品：干细胞导航器和RAPIDS平台\n\n- 干细胞导航器是一种创新的医疗机器人平台，旨在通过电磁驱动技术，准确地将药物送达疼痛区域，最大限度地提高治疗效果，并以微尺寸支架结合治疗材料的方式进行靶向治疗。\n- 微尺寸支架可以封装干细胞、生物制剂和常规药物，实现微创手术。\n- RAPIDS是一种最先进的一站式系统，可在疫情时代最大限度地减少医务人员与患者之间的交叉感染，实现非面对面采样和分子诊断。\n- 这是全球首个可以远程控制采集标本的医疗机器人系统，能够实现无接触和远程控制的咽鼻和口腔标本采集，避免卫生工作者暴露于疫情疾病的风险。"
}